Jump to content

Metaphedrine

From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Citation bot (talk | contribs) at 11:17, 2 November 2024 (Altered doi-broken-date. | Use this bot. Report bugs. | #UCB_CommandLine). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)
Metaphedrine
Legal status
Legal status
Identifiers
  • N-methyl-1-(3-methylphenyl)propan-2-amine
CAS Number
PubChem CID
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC11H17N
Molar mass163.264 g·mol−1
3D model (JSmol)
  • CC1=CC(=CC=C1)CC(C)NC
  • InChI=1S/C11H17N/c1-9-5-4-6-11(7-9)8-10(2)12-3/h4-7,10,12H,8H2,1-3H3
  • Key:CXVNKBVJDKMLOH-UHFFFAOYSA-N

3-Methylmethamphetamine (3-MMA) or Metaphedrine is an amphetamine derivative which has been sold as a designer drug, first being reported in Sweden in 2021.[1]

See also

[edit]

References

[edit]
  1. ^ European Monitoring Centre for Drugs and Drug Addiction. (June 2022). New psychoactive substances: 25 years of early warning and response in Europe. An update from the EU Early Warning System (PDF). European Monitoring Centre for Drugs and Drug Addiction. doi:10.2810/882318 (inactive 2024-11-02). ISBN 978-92-9497-737-3.{{cite book}}: CS1 maint: DOI inactive as of November 2024 (link)